Genmab/$GMAB
About Genmab
Ticker
Industry
Headquarters
Employees
Genmab Metrics
$14B
1.31
$17.02
0.86
-
Price and volume
Market cap
$14B
Beta
0.86
52-week high
$31.88
52-week low
$18.64
Average daily volume
1.6M
Financial strength
Current ratio
5.248
Quick ratio
5.236
Long term debt to equity
2.553
Total debt to equity
2.804
Interest coverage (TTM)
58.99%
Management effectiveness
Return on assets (TTM)
10.91%
Return on equity (TTM)
22.97%
Valuation
Price to earnings (TTM)
1.313
Price to revenue (TTM)
0.475
Price to book
2.74
Price to tangible book (TTM)
4.61
Price to free cash flow (TTM)
1.37
Growth
Revenue change (TTM)
30.67%
Earnings per share change (TTM)
83.82%
3-year revenue growth (CAGR)
36.75%
3-year earnings per share growth (CAGR)
39.43%
What the Analysts think about Genmab
Analyst Ratings
Genmab Financial Performance
Income Statement
Q3 24
QoQ growth
$37B
-39.75%
$45B
107.52%
37.65%
6.78%
Genmab Earnings Performance
Earnings per share (EPS)
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
$3.69
$2.85
$2.45
$2.42
-
$3.55
$2.61
$2.05
$2.31
$3.94
3.94%
9.20%
19.51%
4.63%
-
Genmab News
What’s the current market cap for Genmab stock?
What is the P/E ratio for Genmab stock?
Does Genmab stock pay dividends?
No, Genmab (GMAB) stock does not pay dividends to its shareholders as of February 23, 2025.
When is the next Genmab dividend payment date?
Genmab (GMAB) stock does not pay dividends to its shareholders.
What is the beta indicator for Genmab?
Genmab (GMAB) has a beta rating of 0.86. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.